Menu
Back to Journals » OncoTargets and Therapy » Volume 4 » default
OncoTargets and Therapy
ISSN: 1178-6930
- View all (6402)
- Volume 16, 2023 (111)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Archive: Volume 4, 2011
Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
Deshpande H, Marler V, Sosa JA
OncoTargets and Therapy 2011, 4:209-215
Published Date: 9 December 2011
Surgical management of retrorectal tumors: a retrospective study of a 9-year experience in a single institution
Lin CZ, Jin KT, Lan HR, Teng LS, Lin JJ, Chen WB
OncoTargets and Therapy 2011, 4:203-208
Published Date: 30 November 2011
Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies
Kobayakawa M, Kojima Y
OncoTargets and Therapy 2011, 4:193-201
Published Date: 15 November 2011
Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer
Muñoz-Couselo E, Pérez-García J, Cortés J
OncoTargets and Therapy 2011, 4:185-192
Published Date: 14 November 2011
Targeted treatment for chronic lymphocytic leukemia
Masood A, Sher T, Paulus A, Miller KC, Chitta KS, Chanan-Khan A
OncoTargets and Therapy 2011, 4:169-183
Published Date: 4 November 2011
Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia
Hoeksema KA, Jayanthan A, Cooper T, Gore L, Trippett T, Boklan J, Arceci RJ, Narendran A
OncoTargets and Therapy 2011, 4:149-168
Published Date: 5 September 2011
Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents
Khan MK, Khan N, Almasan A, Macklis R
OncoTargets and Therapy 2011, 4:137-148
Published Date: 9 August 2011
Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
Yamamoto Y, Kawano I, Iwase H
OncoTargets and Therapy 2011, 4:123-136
Published Date: 18 July 2011
The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine
Ahmad EI, Gawish HH, Al Azizi NMA, Elhefni AM
OncoTargets and Therapy 2011, 4:115-121
Published Date: 15 July 2011
Current therapeutic strategies for invasive and metastatic bladder cancer
Vishnu P, Mathew J, Tan WW
OncoTargets and Therapy 2011, 4:97-113
Published Date: 11 July 2011
Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments
Gupta SG, Carballido ES, Fishman M
OncoTargets and Therapy 2011, 4:79-96
Published Date: 29 June 2011
Downregulation of CD44 reduces doxorubicin resistance of CD44+CD24- breast cancer cells
Phuc PV, Nhan PLC, Nhung TH, Tam NT, Hoang NM, Tue VG, Thuy DT, Ngoc PK
OncoTargets and Therapy 2011, 4:71-78
Published Date: 21 June 2011
Antioxidant oils and Salmonella enterica Typhimurium reduce tumor in an experimental model of hepatic metastasis
Sorenson BS, Banton KL, Augustin LB, Leonard AS, Saltzman DA
OncoTargets and Therapy 2011, 4:59-69
Published Date: 30 May 2011
Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC
Ballas MS, Chachoua A
OncoTargets and Therapy 2011, 4:43-58
Published Date: 30 May 2011
An update on TroVax® for the treatment of progressive castration-resistant prostate cancer
Abern M, Kaufman HL, Latchamsetty K
OncoTargets and Therapy 2011, 4:33-41
Published Date: 24 May 2011
Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets
Kounnis V, Ioachim E, Svoboda M, Tzakos A, Sainis I, Thalhammer T, Steiner G, Briasoulis E
OncoTargets and Therapy 2011, 4:27-32
Published Date: 8 April 2011
New developments in the treatment of metastatic gastric cancer: focus on trastuzumab
Rose JS, Bekaii-Saab TS
OncoTargets and Therapy 2011, 4:21-26
Published Date: 24 March 2011
Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis
William C Dooley, James C Wurzer, Mohamed Megahy, et al
OncoTargets and Therapy 2011, 4:13-20
Published Date: 12 January 2011
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection
Carmen Criscitiello, Debora Fumagalli, Kamal S Saini, et al
OncoTargets and Therapy 2011, 4:1-11
Published Date: 17 December 2010